Cost effectiveness


PUBLISHED: 2017 CATEGORY: Health care providers TYPE: External Link Economic evaluations of vaccines in Canada: a scoping review

Economic evaluations of vaccines in Canada: a scoping review

This study aims to summarize and describe the evolution of published economic evaluations of vaccines in Canada, thereby outlining the current state of this expanding and meaningful research.

Authors: Rafferty ERS et al.
Journal Issue: 7
Journal Title: Cost Effectiveness and Resource Allocation
Journal Volume: 15
Publisher: BioMed Central

PUBLISHED: 2016 CATEGORY: Health care providers TYPE: External Link Cost benefit of vaccines (from Canadian Immunization Guide)

Cost benefit of vaccines (from Canadian Immunization Guide)

Vaccine-preventable diseases result in significant costs to individuals, the health care system, and society, including costs associated with absenteeism from work or school, visits to health care providers, hospitalizations, and premature deaths. In addition to being one of the most beneficial, immunization is also one of the most cost-effective public health interventions.

Corporate Authors: National Advisory Committee on Immunization
Publisher: Government of Canada

PUBLISHED: 2016 CATEGORY: Les fournisseurs de soins TYPE: External Link Coûts-avantages des vaccins (du Guide canadien d'immunisation)

Coûts-avantages des vaccins (du Guide canadien d'immunisation)

Les maladies évitables par la vaccination engendrent des coûts considérables pour les individus, le système de soins de santé et la société, notamment des coûts associés à l’absentéisme au travail ou à l’école, aux consultations auprès de fournisseurs de soins de santé, aux hospitalisations et aux décès prématurés. L’immunisation est l’une des interventions en santé publique les plus bénéfiques et les plus économiques.

Corporate Authors: Comité consultatif national de l'immunisation
Publisher: Gouvernement du Canada

PUBLISHED: 2016 CATEGORY: Health care providers TYPE: External Link Economic evaluation of vaccines in Canada: A systematic review

Economic evaluation of vaccines in Canada: A systematic review

A systematic review of economic evaluations of vaccines in Canada to determine and summarize  comprehensiveness across jurisdictions, studied vaccines, funding sources, study designs, research quality, and changes over time.

Authors: Chit A
Journal Issue: 5
Journal Title: Human Vaccines & Immunotherapeutics
Journal Volume: 12
Publisher: National Center for Biotechnology Information

PUBLISHED: 2015 CATEGORY: Health care providers TYPE: External Link Systematic Review of the Cost-Effectiveness of Influenza Immunization Programs: A Canadian Perspective

Systematic Review of the Cost-Effectiveness of Influenza Immunization Programs: A Canadian Perspective

In Canada, currently no national seasonal influenza immunization program exists. To better inform policy, the cost-effectiveness of influenza immunization programs was examined.  Using a best-evidence synthesis approach, 31 economic evaluations were reviewed. Subgroups emerged from the literature, including pregnant and post-partum women, children, and healthy adults. Generally, from the societal and healthcare system perspective, vaccination was cost-effective. For pregnant and post-partum women, vaccinating all versus only high risk was cost-effective. For children (6 months to18 years), vaccinating all versus only high risk was cost effective, especially for infants, toddlers, and adolescents. For healthy working age adults (19 to 64 years), results were mixed, and sensitive to vaccine efficacy, uptake, and productivity loss.
For adults with co-morbidities and healthcare workers, vaccination was cost-effective. In Canada, six provinces (AB, SK, MB, ON, NS, NL) and all territories offer universal programs as of 2014. Three provinces (BC, QC, NB) offer programs targeting high risk groups only.
Authors: Ting E
Publisher: The Hospital for Sick Children - Child Health Evaluative Sciences

PUBLISHED: 2012 CATEGORY: Health care providers TYPE: External Link Cost effectiveness of infant vaccination for rotavirus in Canada

Cost effectiveness of infant vaccination for rotavirus in Canada

Rotavirus is the main cause of gastroenteritis in Canadian children younger than five years of age, resulting in significant morbidity and cost. The present study provides evidence on the cost-effectiveness of two alternative rotavirus vaccinations available in Canada.

Authors: Coyle D et al.
Journal Issue: 2
Journal Title: Can J Infect Dis Med Microbiol
Journal Volume: 23
Publisher: National Center for Biotechnology Information, U.S. National Library of Medicine

PUBLISHED: 2012 CATEGORY: Health care providers TYPE: External Link Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada

Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada

Many jurisdictions have implemented universal human papillomavirus (HPV) immunization programs in preadolescent females. However, the cost-effectiveness of modified cervical screening guidelines and/or catch-up immunization in older females in Canada has not been evaluated. Researchers conducted a cost-utility analysis of screening and immunization with the bivalent vaccine for the Canadian setting from the Ministry of Health perspective. They used a dynamic model to capture herd immunity and included cross-protection against strains not included in the vaccine. They found that adding catch-up immunization to the current program would be cost-effective, and that combining catch-up immunization with delaying the age at which screening is first initiated could result in cost savings and net health gains.

Journal Issue: 2
Journal Title: Vaccine
Journal Volume: 30

PUBLISHED: 2010 CATEGORY: Health care providers, Parents, Adults TYPE: PDFVaccine research, development and awareness : front line medicine

Vaccine research, development and awareness : front line medicine

A special information supplement from the March 5, 2010 issue of the Globe and Mail that celebrates and promotes Canada’s contributions in the development and distribution of disease-fighting vaccines.

Corporate Authors: Globe and Mail
Publisher: Globe and Mail

PUBLISHED: 2009 CATEGORY: Health care providers TYPE: External Link Cost Effectiveness of Herpes Zoster Vaccine in Canada

Cost Effectiveness of Herpes Zoster Vaccine in Canada

Compares the incremental cost and health benefits of herpes zoster (HZ) vaccine over status quo (no HZ vaccine) from the perspective of the Canadian healthcare payer.

Authors: Mehdi N et al.
Journal Issue: 12
Journal Title: PharmacoEconomics
Journal Volume: 27
Publisher: Springer

PUBLISHED: 2009 CATEGORY: Les fournisseurs de soins TYPE: External Link Immunisation, infections et le rôle de l'école dans la vaccination

Immunisation, infections et le rôle de l'école dans la vaccination

L'immunisation des enfants et des jeunes en milieu scolaire est considérée à nouveau comme une mesure économique et avantageuse tant pour la santé que pour le rendement scolaire. Le présent article examine certaines données probantes, commente des expériences au Canada et dans d'autres pays et mentionne quelques bons programmes.

Authors: Shannon M, Andrew C
Corporate Authors: Association canadienne pour la santé en milieu scolaire
Publisher: Fédération canadienne des enseignantes et enseignants